Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Kolta

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|March 28, 2018
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)Jean-Luc Meynard, Laetitia Moinot, Roland Landman, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 studyChristine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Rheumatology (Oxford, England)|December 1, 2021
Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scansChristian Roux, Antoine Rozes, Daniel Reizine, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2004
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS StudyClaus C Glüer, Richard Eastell, David M Reid, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohortVéronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 7, 2006
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factorsChristian Roux, Jean-Yves Reginster, Jacques Fechtenbaum, et al.
Current HIV Research|January 5, 2011
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trialSami Kolta, Philippe Flandre, Philippe Ngo Van, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 13, 2005
Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null miceLaurence Nicolet-Barousse, Anne Blanchard, Christian Roux, et al.
Joint Bone Spine|January 28, 2014
Difficulties in the diagnosis of vertebral fracture in men: agreement between doctorsJacques Fechtenbaum, Karine Briot, Simon Paternotte, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2019
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL studyChristine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|March 28, 2018
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)Jean-Luc Meynard, Laetitia Moinot, Roland Landman, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 studyChristine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Rheumatology (Oxford, England)|December 1, 2021
Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scansChristian Roux, Antoine Rozes, Daniel Reizine, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2004
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS StudyClaus C Glüer, Richard Eastell, David M Reid, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohortVéronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 7, 2006
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factorsChristian Roux, Jean-Yves Reginster, Jacques Fechtenbaum, et al.
Current HIV Research|January 5, 2011
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trialSami Kolta, Philippe Flandre, Philippe Ngo Van, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 13, 2005
Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null miceLaurence Nicolet-Barousse, Anne Blanchard, Christian Roux, et al.
Joint Bone Spine|January 28, 2014
Difficulties in the diagnosis of vertebral fracture in men: agreement between doctorsJacques Fechtenbaum, Karine Briot, Simon Paternotte, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2019
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL studyChristine Katlama, Lambert Assoumou, Marc-Antoine Valantin, et al.
Pageof 5